Constraining the use of antibiotics: Applying Scanlon's contractualism

Journal of Medical Ethics

Volumn 38, Issue 8, 2012, Pages 465-469

  Millar, Michael ^a  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL PRACTICE; CROSS INFECTION; DRUG UTILIZATION; HEALTH CARE POLICY; HUMAN; MEDICAL EDUCATION; METHODOLOGY; MICROBIOLOGY; MULTIDRUG RESISTANCE; PRACTICE GUIDELINE; PRESCRIPTION; STANDARD; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG PRESCRIPTIONS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG UTILIZATION; EDUCATION, MEDICAL, CONTINUING; HEALTH POLICY; HUMANS; LONDON; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC;

EID: 84866343241     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2011-100256     Document Type: Article

References (30)

1. Morel C, Mossialos E. Stoking the antibiotic pipeline. BMJ 2010;340:1115e18.
2. Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and metaanalysis. BMJ 2010;340:c2096.
3. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011;108:4554e61.
4. Jakobsson HE, Jernberg C, Andersson AF, et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLos One 2010;5:e9836.
5. Martinez JL. Environmental pollution by antibiotics and antibiotic resistance determinants. Environ Pollut 2009;157:2893e902.
6. So AD, Carr O, Gupta N. Tackling antibiotic resistance. BMJ 2010;340:c2071.
7. Smith GE, Smith S, Heatlie H, et al. What has happened to antimicrobial usage in primary care in the United Kingdom since the SMAC report?dDescription of trends in antimicrobial usage using the General Practice Research Database. J Public Health (Oxf) 2004;26:359e64.
8. World Health Organisation. 2011. http://www.euro.who.int/en/who-we-are/whd/world-health-day-2011-antibiotic-resistance-no-action-today,-no-cure-tomorrow (accessed Aug 2011).
9. Enne VI. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done? J Antimicrob Chemother 2010;65:179e82.
10. Warren J, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745e58.
11. Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhoea in adults in the United States. Clin Infect Dis 2007;44(Suppl 3):S84e101.
12. Daneman N, Low DE, McGeer A, et al. At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia. Clin Infect Dis 2008;46:1132.
13. National Institute for health and clinical Excellence (January 2009). The guidelines manual. London: National Institute for health and clinical Excellence, 2009. http://www.nice.org.uk
14. Coast J. Is economic evaluation in touch with society's health values? BMJ 2004;329:1233e6.
15. Wolff J. Risk, Fear, Blame, Shame and the Regulation of public Safety. Econ Philosoph 2006;22:409e27.
16. Coast J, Smith RD, Millar MR. Superbugs: should antimicrobial resistance be included as a cost in economic evaluation. Health Econ 1996;5:217e26.
17. Scanlon T. What We Owe To Each Other. Harvard: Harvard University Press, 1998.
18. Lenman J. Contractualism and risk imposition. Polit Philos Econ 2008;7: 99e122.
19. Fiscella K, Franks P, Zwanziger J, et al. Risk aversion and costs: a comparison of family physicians and general internists. J Fam Pract 2000;49:12e17.
20. Health and Safety Executive. Reducing Risks, Protecting People. UK: Health and Safety Executive, 2011.
21. Mainous AG 3rd, Everett CJ, Post RE, et al. Availability of antibiotics for purchase without a prescription on the internet. Ann Fam Med 2009;7: 431e5.
22. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: a molecular, biological and epidemiological study. Lancet Infect Dis 2010;10:597e602.
23. Sandel M. It's immoral to buy the right to pollute. NY Times 15 December 1997: A23.
24. Marcus EL, Clarfield M, Moses AE. Ethical issues in antibiotic therapy. Clin Infect Dis 2001;33:1697e705.
25. D'Agata E, Mitchell SL. Patterns of antimicrobial use among nursing home residents with advanced dementia. Arch Intern Med 2008;168:357e62.
26. Givens JL, Jones RN, Shaffer ML, et al. Survival and comfort after treatment of pneumonia in advanced dementia. Arch Intern Med 2010;170:1102e7.
27. Schwaber MJ, Carmeli Y. Antibiotic therapy in the demented elderly population. Arch Intern Med 2008;168:349e50.
28. Levin PD, Simor AE, Moses AE, et al. End-of-life treatment and bacterial antibiotic resistance: a potential association. Chest 2010;138:588e94.
29. Rollins B. Annual meeting keynote address: animal agriculture and emerging social ethics for animals. J Anim Sci 2004;82:955e65.
30. http://www.cqc.org.uk/media/infection-control-milton-keynes-hospital-must-improvesays-regulatorref